INTS – intensity therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review [Yahoo! Finance]
Drug Monitoring Committee Authorizes Continuation of Intensity Therapeutics' Ongoing Global Randomized Phase 3 Sarcoma Trial ("INVINCIBLE-3 Study") Following Periodic Review
Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6 [Yahoo! Finance]
Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6
Form SCHEDULE 13G INTENSITY THERAPEUTICS, Filed by: ARMISTICE CAPITAL, LLC
Form SCHEDULE 13G INTENSITY THERAPEUTICS, Filed by: SAPIENT CAPITAL LLC
Form 424B3 INTENSITY THERAPEUTICS,
Form EFFECT INTENSITY THERAPEUTICS,
Form S-1 INTENSITY THERAPEUTICS,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.